EPAS1 and cancer: In pancreatic ductal adenocarcinoma (PDAC), HIF‐1α and HIF‐2α also exhibit opposing effects on tumor progression: HIF‐1α deletion enhances tumor proliferation and immune infiltration, whereas loss of HIF‐2α reduces the progression of precursor lesions, further underscoring the nuanced roles of these factors in cancer.208, 209